These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28069154)

  • 1. The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin's and non-Hodgkin's lymphomas: A scoping review.
    Fox P; Darley A; Furlong E; Miaskowski C; Patiraki E; Armes J; Ream E; Papadopoulou C; McCann L; Kearney N; Maguire R
    Eur J Oncol Nurs; 2017 Feb; 26():63-82. PubMed ID: 28069154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART).
    Maguire R; McCann L; Kotronoulas G; Kearney N; Ream E; Armes J; Patiraki E; Furlong E; Fox P; Gaiger A; McCrone P; Berg G; Miaskowski C; Cardone A; Orr D; Flowerday A; Katsaragakis S; Darley A; Lubowitzki S; Harris J; Skene S; Miller M; Moore M; Lewis L; DeSouza N; Donnan PT
    BMJ; 2021 Jul; 374():n1647. PubMed ID: 34289996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The eSMART study protocol: a randomised controlled trial to evaluate electronic symptom management using the advanced symptom management system (ASyMS) remote technology for patients with cancer.
    Maguire R; Fox PA; McCann L; Miaskowski C; Kotronoulas G; Miller M; Furlong E; Ream E; Armes J; Patiraki E; Gaiger A; Berg GV; Flowerday A; Donnan P; McCrone P; Apostolidis K; Harris J; Katsaragakis S; Buick AR; Kearney N
    BMJ Open; 2017 Jun; 7(5):e015016. PubMed ID: 28592577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity.
    Kearney N; McCann L; Norrie J; Taylor L; Gray P; McGee-Lennon M; Sage M; Miller M; Maguire R
    Support Care Cancer; 2009 Apr; 17(4):437-44. PubMed ID: 18953579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of infection among patients with non-metastatic solid tumors or non-Hodgkin's lymphoma receiving myelosuppressive chemotherapy and antimicrobial prophylaxis in US clinical practice.
    Weycker D; Chandler D; Barron R; Xu H; Wu H; Edelsberg J; Lyman GH
    J Oncol Pharm Pract; 2017 Jan; 23(1):33-42. PubMed ID: 26568602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas.
    Bremer K
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma.
    Jakovljevic M; Gutzwiller F; Schwenkglenks M; Milovanovic O; Rancic N; Varjacic M; Stojadinovic D; Dagovic A; Matter-Walstra K
    J BUON; 2014; 19(4):1111-20. PubMed ID: 25536624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy dose density in early-stage breast cancer and non-Hodgkin's lymphoma.
    Goldspiel BR
    Pharmacotherapy; 2004 Oct; 24(10):1347-57. PubMed ID: 15628832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in chemotherapy of the lymphomas: a review.
    Williams CK
    Afr J Med Med Sci; 1987 Dec; 16(4):163-9. PubMed ID: 2830776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
    Specht L
    Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.
    Tessoulin B; Thomare P; Delande E; Moynard J; Gastinne T; Moreau A; Bossard C; Mahé B; Blin N; Dubruille V; Touzeau C; Boudreault JS; Perrin F; Lok A; Guillaume T; Garnier A; Peterlin P; Gallas P; Chevallier P; Moreau P; Le Gouill S
    Ann Hematol; 2017 Jun; 96(6):943-950. PubMed ID: 28374163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy.
    Kiserud CE; Fosså A; Bjøro T; Holte H; Cvancarova M; Fosså SD
    Br J Cancer; 2009 Feb; 100(3):455-63. PubMed ID: 19156143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary non-Hodgkin's lymphomas of the breast. Report of two cases].
    Fatnassi R; Bellara I
    J Gynecol Obstet Biol Reprod (Paris); 2005 Nov; 34(7 Pt 1):721-4. PubMed ID: 16270012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease.
    Copelan EA; Ceselski SK; Ezzone SA; Lasky LC; Penza SL; Bechtel TP; Klein JL; Hehmeyer DM; Scholl MD; Marshall DD; Elder PJ; Risley GL; Avalos BR
    J Clin Oncol; 1997 Feb; 15(2):759-65. PubMed ID: 9053502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
    Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
    J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy during Pregnancy: Cases of Hodgkin's and Non-Hodgkin's Lymphoma, Chronic Myeloid Leukemia, Breast Cancer, Nasopharyngeal Cancer, and Choriocarcinoma.
    Beksac K; Orgul G; Ozyuncu O; Yurdakok M; Altundag K; Beksac MS
    Oncol Res Treat; 2017; 40(7-8):441-445. PubMed ID: 28700986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Patient Remote Intervention and Symptom Management System (PRISMS) - a Telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trial.
    Breen S; Ritchie D; Schofield P; Hsueh YS; Gough K; Santamaria N; Kamateros R; Maguire R; Kearney N; Aranda S
    Trials; 2015 Oct; 16():472. PubMed ID: 26481873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS) to monitor and manage chemotherapy related toxicity.
    McCann L; Maguire R; Miller M; Kearney N
    Eur J Cancer Care (Engl); 2009 Mar; 18(2):156-64. PubMed ID: 19267731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.